Mirna Therapeutics, Inc. (MIRN) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 91 transactions totaling $89.0M, demonstrating a bullish sentiment with $89.0M in net insider flow. The most recent transaction on Dec 1, 2016 involved a sale of 280 shares valued at $400.
No significant insider buying has been recorded for MIRN in the recent period.
No significant insider selling has been recorded for MIRN in the recent period.
Based on recent SEC filings, insider sentiment for MIRN is bullish with an Insider Alignment Score of 100/100 and a net flow of $89.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Mirna Therapeutics, Inc. (MIRN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading MIRN stock, having executed 91 transactions in the past 90 days. The most active insider is Inc Pfizer (Executive), who has made 3 transactions totaling $6.7M.
Get notified when executives and directors at MIRN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 1, 2016 | Irvin Jon | Executive | Sale | 280 | $1.43 | $400 | |
| Nov 11, 2016 | Irvin Jon | Executive | Sale | 150 | $1.45 | $218 | |
| Nov 1, 2016 | Irvin Jon | Executive | Sale | 280 | $1.28 | $358 | |
| Oct 3, 2016 | Irvin Jon | Executive | Sale | 250 | $1.93 | $483 | |
| Oct 6, 2015 | M. Alleva Lawrence | Executive | Other | 207 | $N/A | $0 | |
| Oct 6, 2015 | Powell Michael | Executive | Other | 289,841 | $N/A | $0 | |
| Oct 6, 2015 | Powell Michael | Executive | Purchase | 857,142 | $7.00 | $6.0M | Large |
| Oct 6, 2015 | Winkler Matthew | Executive | Other | 62,582 | $N/A | $0 | |
| Oct 6, 2015 | Winkler Matthew | Executive | Other | 8,408 | $N/A | $0 | |
| Oct 6, 2015 | Winkler Matthew | Executive | Other | 8,408 | $N/A | $0 | |
| Oct 6, 2015 | Winkler Matthew | Executive | Other | 8,408 | $N/A | $0 | |
| Oct 6, 2015 | James Barrett M. | Executive | Purchase | 857,142 | $7.00 | $6.0M | Large |
| Oct 6, 2015 | James Barrett M. | Executive | Other | 31,650 | $N/A | $0 | |
| Oct 6, 2015 | James Barrett M. | Executive | Other | 257,516 | $N/A | $0 | |
| Oct 6, 2015 | J. Barris Peter | Executive | Purchase | 857,142 | $7.00 | $6.0M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 15 | $89.0M | 98.2% |
Other(J) | 32 | $1.7M | 1.8% |
Sale(S) | 4 | $1.5K | 0.0% |
Conversion(C) | 40 | $0 | 0.0% |
Insiders at Mirna Therapeutics, Inc. are accumulating shares at an accelerated pace. With 18 insiders making 91 transactions totaling $89.0M in purchases versus $1.5K in sales, the net buying activity of $89.0M signals strong executive confidence. Inc Pfizer (Executive) leads the buying activity with $6.7M in transactions across all time.